Another inspiring event of the Role Model Series with two guests this time: Amira Ghozali, Director, Strategy and Market Intelligence, Aptar Pharma, and Bas van Buijtenen, IDP-C20, AMP05, CEO, LTS Lohmann Therapie-Systeme AG.
As a reminder, each Role Model Event features one or several inspiring guest speakers from the Swiss leadership community who are strongly promoting and establishing these topics in his or her work environment. In a very personal and practical way, the guests talk about their experiences, learnings and best practices on their way to bring more gender equality into the business world. The talk is followed by networking circles for attendees to network, share experiences and learn from each other.
The two will talk about how they launched a DEI initiative at Aptar Pharma in 2018 with very little means and became a company-wide program that led to Aptar Pharma being recognized among the Global Top 10 female-friendly companies by Forbes.
Starting small with Diversity, Equity, and Inclusion (DEI) might very well lead to big results. At least it did for Amira and Bas when they worked together at Aptar Pharma, an innovative drug delivery company with 13,000 employees around the world.
The Aptar DEI initiative began with minimal resources. It was a grassroots project that spread from a single business unit to the whole company.
Join this event to hear how they did it and what the key success factors were for this program.
Director, Strategy & Market Intelligence, Aptar Pharma
In her current role since 2020, Amira joined Aptar Pharma in 2017. She is experienced in Competitive/Market Intelligence, Strategy, Business Development, and Innovation in the Pharmaceutical, Chemical, and Software industries. Next to her role, Amira is also Chair of the first employee resource group within Aptar Group, launched in 2020, named ALIGN, which focuses on Gender Balance topics, as part of the global DEI Strategy. Aptar was named a Global Top 10 Female-Friendly Company by Forbes and is number eight out of the 300 companies included for 2021.
Bas van Buijtenen
IDP-C20, AMP05, CEO, LTS Lohmann Therapie-Systeme AG
As CEO, Bas is chair of the Executive Board at LTS since mid-2020, He also serves as a non-executive board member in several other companies, including Microphyt and ABC Transfer. When Bas and Amira worked together on the beginnings of their D&I initiative, he was President of the Global Injectables Division at Aptar Pharma.
Committee Member INSEAD Women in Business
Kathrin Niederlaender is an Operations executive that develops and deploys strategy across Operations with a digital touch in the Consumer goods sector. She is passionate about advancing diversity and inclusion, connecting and developing people.
Podcast host of Fish in the Boardroom & Committee Member INSEAD Women in Business
Andrea is a marketing and sales executive with an international career in the medical device industry. She launched the podcast Fish in the Boardroom in 2020 to raise a discussion on how to bring more Diversity, Equity & Inclusion in Swiss Leadership.